65岁以上患者种植体早期失败率与年轻患者相当
按年龄分组后,≥80岁组EIL率略高但无统计学意义。匹配分析显示老年与年轻患者EIL率无显著差异,衰老似乎不影响骨结合。
要点
- ≥65岁患者种植体早期失败率低,与35-<55岁患者相当。
- ≥80岁患者EIL率有轻微升高趋势,但差异无统计学意义。
- 年龄本身不构成种植禁忌,无需仅因高龄拒绝种植治疗。
核心结论
- ≥65岁老年患者种植体早期失败率与35-<55岁年轻患者相似,均处于较低水平。
- ≥80岁患者可能存在EIL率轻微升高的趋势,但统计学证据不足。
- 衰老似乎不损害种植体骨结合,即使有影响也仅限于生命后期且程度轻微。
研究设计与样本
- 回顾性研究,纳入大学附属机构11.5年间所有≥65岁种植患者,要求资料完整且随访至修复完成。
- 从老年患者中每例取一枚种植体,按性别、种植区域、吸烟状态和植骨情况与同一诊所35-<55岁年轻患者的一枚种植体进行匹配,成功匹配347对。
- 对全部老年人群及匹配后的老年与年轻组,统计分析局部和全身因素对EIL的潜在影响。
主要发现
- 全部老年患者中,10例患者各发生1枚EIL,种植体水平EIL率为0.66%,患者水平为2.25%。
- 按年龄分为65-69.9岁(n=213)、70-74.9岁(n=111)、75-79.9岁(n=80)和≥80岁(n=40)四组,种植体水平EIL率分别为0.41%、0.83%、0.34%和2.26%(p=.102),患者水平分别为1.41%、2.70%、1.25%和7.50%(p=.104)。
- 多水平分析显示年龄增长与EIL率升高之间仅有弱证据关联(p=.090)。
- 匹配分析中,老年组和年轻组EIL分别为5枚(1.44%)和9枚(2.59%),差异无统计学意义(p=.280)。
- EIL与任何全身疾病或用药均无关联。
临床怎么用
- 对于≥65岁无特殊禁忌的患者,种植治疗决策不应仅因年龄而改变。
- 对≥80岁患者可保持常规种植风险评估,无需额外因年龄增加预防性干预。
- 全身疾病和用药情况不影响EIL风险,但仍需按常规进行术前评估。
局限性
- 本研究为回顾性设计,可能存在选择偏倚和信息偏倚。
- ≥80岁亚组样本量较小(n=40),统计效能有限。
- 匹配分析仅覆盖347对,部分老年患者未能匹配。
- EIL事件数较少(共10例),限制多因素分析的可靠性。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
OBJECTIVES: To assess, retrospectively, whether older age has an impact on implant osseointegration when compared with younger age. METHODS: All patients ≥65 years old at implant installation, in an university setting over a time-period of 11.5 years, with complete anamnestic data and follow-up until prosthetic restoration were included, and any early implant loss (EIL; i.e. lack of osseointegration prior to or at the time-point of prosthetic restoration) was recorded. Further, one implant, from each of the elderly patients, was attempted matched to one implant in a younger patient (35 to <55 years old at implant installation) from the same clinic based on (a) gender, (b) implant region, (c) smoking status and (d) bone grafting prior to/simultaneously with implant installation. The potential impact of various local and systemic factors on EIL in the entire elderly population, and in the matched elderly and younger patient group was statistically assessed. RESULTS: Four hundred forty-four patients ≥65 years old (range 65.1-91.3; 56.8% female) receiving 1,517 implants were identified; 10 patients had one EIL each (implant/patient level: 0.66/2.25%). Splitting this patient cohort additionally into four age groups [65-69.9 (n = 213), 70-74.9 (n = 111), 75-79.9 (n = 80) and ≥80 (n = 40)], EIL was on the implant level 0.41, 0.83, 0.34 and 2.26%, respectively, (p = .102) and on the patient level 1.41, 2.70, 1.25 and 7.50%, respectively, (p = .104); multilevel analysis showed weak evidence of association of increasing age with higher EIL rate (p = .090). Matching was possible in 347 cases, and 5 (1.44%) and 9 (2.59%) EIL in the elderly and younger patients, respectively, were observed (p = .280). EIL could not be associated with any systemic condition or medication intake. CONCLUSIONS: Elderly patients ≥65 years old presented a similarly low EIL rate as younger patients 35 to <55 years old, while patients ≥80 years old may have a slight tendency for a higher EIL rate. Hence, ageing does not seem to compromise osseointegration, and if at all, then only slightly and at a later stage of life.
引用
- Bertl K, Ebner M, Knibbe M, et al. How old is old for implant therapy in terms of early implant losses? J Clin Periodontol. 2019. PMID: 31529723. doi:10.1111/jcpe.13199
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。